BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30714126)

  • 1. Long-term survivors of childhood, adolescent and young adult non-Hodgkin lymphoma.
    Ehrhardt MJ; Hochberg J; Bjornard KL; Brinkman TM
    Br J Haematol; 2019 Jun; 185(6):1099-1110. PubMed ID: 30714126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study.
    Ehrhardt MJ; Chen Y; Sandlund JT; Bluhm EC; Hayashi RJ; Becktell K; Leisenring WM; Metzger ML; Ness KK; Krull KR; Oeffinger KC; Gibson TM; Cairo MS; Gross TG; Robison LL; Armstrong GT; Yasui Y; Hudson MM; Mulrooney DA
    J Clin Oncol; 2019 Oct; 37(28):2556-2570. PubMed ID: 31283408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of childhood non-Hodgkin lymphoma.
    Ehrhardt MJ; Mulrooney DA; Li C; Baassiri MJ; Bjornard K; Sandlund JT; Brinkman TM; Huang IC; Srivastava DK; Ness KK; Robison LL; Hudson MM; Krull KR
    Cancer; 2018 Jan; 124(2):417-425. PubMed ID: 28915338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late outcomes of adult survivors of childhood non-Hodgkin lymphoma: A report from the St. Jude Lifetime Cohort Study.
    Ehrhardt MJ; Sandlund JT; Zhang N; Liu W; Ness KK; Bhakta N; Chemaitilly W; Krull KR; Brinkman TM; Crom DB; Kun L; Kaste SC; Armstrong GT; Green DM; Srivastava K; Robison LL; Hudson MM; Mulrooney DA
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27860222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and epidemiology of non-Hodgkin lymphoma and risk of second malignancy among 22 466 survivors in Israel with 30 years of follow-up.
    Tadmor T; Liphshitz I; Silverman B; Polliack A
    Hematol Oncol; 2017 Dec; 35(4):599-607. PubMed ID: 27238496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late effects and frontline treatment selection for children with non-Hodgkin lymphoma.
    Ehrhardt MJ; Dixon SB; Belsky J; Hochberg J
    Best Pract Res Clin Haematol; 2023 Mar; 36(1):101443. PubMed ID: 36907640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma.
    Frick MA; Vachani CC; Hampshire MK; Bach C; Arnold-Korzeniowski K; Metz JM; Hill-Kayser CE
    JCO Clin Cancer Inform; 2018 Dec; 2():1-10. PubMed ID: 30652594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
    Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
    Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.
    Attarbaschi A; Carraro E; Abla O; Barzilai-Birenboim S; Bomken S; Brugieres L; Bubanska E; Burkhardt B; Chiang AK; Csoka M; Fedorova A; Jazbec J; Kabickova E; Krenova Z; Lazic J; Loeffen J; Mann G; Niggli F; Miakova N; Osumi T; Ronceray L; Uyttebroeck A; Williams D; Woessmann W; Wrobel G; Pillon M;
    Haematologica; 2016 Dec; 101(12):1581-1591. PubMed ID: 27515251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term fatigue in survivors of non-Hodgkin lymphoma: The Lymphoma Study Association SIMONAL cross-sectional study.
    Mounier N; Anthony S; Busson R; Thieblemont C; Ribrag V; Tilly H; Haioun C; Casasnovas RO; Morschhauser F; Feugier P; Delarue R; Ysebaert L; Sebban C; Broussais-Guillaumot F; Damaj G; Nerich V; Jais JP; Laborde L; Salles G; Henry-Amar M
    Cancer; 2019 Jul; 125(13):2291-2299. PubMed ID: 30901086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
    Ali S; Olszewski AJ
    Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic medical conditions and late effects following non-Hodgkin lymphoma in HIV-uninfected and HIV-infected adolescents and young adults: a population-based study.
    Abrahão R; Li QW; Malogolowkin MH; Alvarez EM; Ribeiro RC; Wun T; Keegan THM
    Br J Haematol; 2020 Aug; 190(3):371-384. PubMed ID: 32080836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of Life is Similar between Long-term Survivors of Indolent and Aggressive Non-Hodgkin Lymphoma.
    Beaven AW; Samsa G; Zimmerman S; Smith SK
    Cancer Invest; 2016 Jul; 34(6):279-85. PubMed ID: 27379565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic literature review of health-related quality of life among aggressive non-Hodgkin lymphoma survivors.
    Lin VW; Blaylock B; Epstein J; Purdum A
    Curr Med Res Opin; 2018 Aug; 34(8):1529-1535. PubMed ID: 29741105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative burden of cardiovascular morbidity in paediatric, adolescent, and young adult survivors of Hodgkin's lymphoma: an analysis from the St Jude Lifetime Cohort Study.
    Bhakta N; Liu Q; Yeo F; Baassiri M; Ehrhardt MJ; Srivastava DK; Metzger ML; Krasin MJ; Ness KK; Hudson MM; Yasui Y; Robison LL
    Lancet Oncol; 2016 Sep; 17(9):1325-34. PubMed ID: 27470081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma.
    Goggins WB; Finkelstein DM; Tsao H
    Cancer; 2001 Feb; 91(4):874-80. PubMed ID: 11241258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause-specific mortality among Medicare beneficiaries with newly diagnosed non-Hodgkin lymphoma subtypes.
    Hester LL; Park SI; Wood WA; Stürmer T; Brookhart MA; Lund JL
    Cancer; 2019 Apr; 125(7):1101-1112. PubMed ID: 30548238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study.
    Chien SH; Liu CJ; Hong YC; Teng CJ; Hu YW; Ku FC; Yeh CM; Chiou TJ; Gau JP; Tzeng CH
    J Cancer Res Clin Oncol; 2015 Nov; 141(11):1995-2004. PubMed ID: 25971624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis.
    Migdady Y; Salhab M; Dang NH; Markham MJ; Olszewski AJ
    Leuk Lymphoma; 2016; 57(3):676-84. PubMed ID: 26428541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.